Patient advocacy groups, industry and individuals join groundbreaking public-private partnership to continue advancing critical Alzheimer's disease research

(Rubenstein Associates, Inc.) The Foundation for the National Institutes of Health (FNIH) announces that patient advocacy groups, private foundations, companies and individual donors have again united in the fight against Alzheimer's disease by donating more than $14 million to launch the third phase of the Alzheimer's Disease Neuroimaging Initiative (ADNI3).

from EurekAlert! - Social and Behavioral Science http://ift.tt/2cJmG7G